+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

Aggressive Fibromatosis Market - Global Forecast 2025-2030 - Product Thumbnail Image

Aggressive Fibromatosis Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Immuno-Oncology Service Market - Global Forecast 2025-2030 - Product Thumbnail Image

Immuno-Oncology Service Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
From
From
Low-Grade Glioma Global Market Report 2025 - Product Thumbnail Image

Low-Grade Glioma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
HER2-Positive Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

HER2-Positive Gastric Cancer - Global Strategic Business Report

  • Report
  • October 2025
  • 281 Pages
  • Global
From
From
Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer - Global Strategic Business Report

  • Report
  • October 2025
  • 582 Pages
  • Global
From
Radioligand Therapy - Global Strategic Business Report - Product Thumbnail Image

Radioligand Therapy - Global Strategic Business Report

  • Report
  • October 2025
  • 381 Pages
  • Global
From
Soft Tissue Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Soft Tissue Sarcoma - Global Strategic Business Report

  • Report
  • October 2025
  • 282 Pages
  • Global
From
Adenoid Cystic Carcinoma - Global Strategic Business Report - Product Thumbnail Image

Adenoid Cystic Carcinoma - Global Strategic Business Report

  • Report
  • October 2025
  • 386 Pages
  • Global
From
Oncology Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Oncology Clinical Trials - Global Strategic Business Report

  • Report
  • October 2025
  • 283 Pages
  • Global
From
Oncology Based In-Vivo CRO - Global Strategic Business Report - Product Thumbnail Image

Oncology Based In-Vivo CRO - Global Strategic Business Report

  • Report
  • October 2025
  • 129 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • October 2025
  • 224 Pages
  • Global
From
Purvalanol a (CDK Inhibitor) Market Report 2025 - Product Thumbnail Image

Purvalanol a (CDK Inhibitor) Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
From
Bispecific T-Cell Engagers Market Report 2025 - Product Thumbnail Image

Bispecific T-Cell Engagers Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Precision Oncology Market Report 2025 - Product Thumbnail Image

Precision Oncology Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Oncology Clinical Trials Market Report 2025 - Product Thumbnail Image

Oncology Clinical Trials Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Radioligand Therapy Market Report 2025 - Product Thumbnail Image

Radioligand Therapy Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more